Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Open Access
- 27 January 2025
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (3) , 108226
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Institute of Neurological Disorders and Stroke
- National Multiple Sclerosis Society
- Henry Ford Health System
This publication has 82 references indexed in Scilit:
- Pyruvate Dehydrogenase-Dependent Metabolic Programming Affects the Oligodendrocyte Maturation and RemyelinationMolecular Neurobiology, 2023
- The role of efferocytosis in neuro-degenerative diseasesNeurological Sciences, 2022
- Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple SclerosisClinical Reviews in Allergy & Immunology, 2021
- Maresin 1 attenuates the inflammatory response and mitochondrial damage in mice with cerebral ischemia/reperfusion in a SIRT1-dependent mannerBrain Research, 2019
- Diversity and environmental adaptation of phagocytic cell metabolismJournal of Leukocyte Biology, 2018
- A Docosahexaenoic Acid-Derived Pro-resolving Agent, Maresin 1, Protects Motor Neuron Cells DeathNeurochemical Research, 2018
- Adoptive transfer of cytokine‐induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 miceGlia, 2014
- Current Concepts in Multiple Sclerosis: Autoimmunity Versus OligodendrogliopathyClinical Reviews in Allergy & Immunology, 2011
- Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitisBrain, Behavior, and Immunity, 2011
- Immunomodulatory Agents for the Treatment of Relapsing Multiple SclerosisArchives of internal medicine (1960), 2002